CP-EPS8-NLS (trifluoroacetate salt)

目录号: GC92272纯度: >95.00%同义词: CP-Epidermal Growth Factor Receptor Kinase Substrate 8-NLS
CP-EPS8-NLS is a cell-penetrating peptide inhibitor of epidermal growth factor receptor kinase substrate 8 (EPS8) nuclear translocation.

CP-EPS8-NLS (trifluoroacetate salt)
规格价格库存数量操作
1mg¥693.00现货
1
5mg¥2,603.00现货
1
10mg¥4,851.00现货
1
25mg¥10,395.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

CP-EPS8-NLS is a cell-penetrating peptide inhibitor of epidermal growth factor receptor kinase substrate 8 (EPS8) nuclear translocation. It induces apoptosis and cell cycle arrest in the G0/G1 phase in THP-1, HL-60, and U937 leukemia cells when used at a concentration of 70 µM. CP-EPS8-NLS (35 or 70 µM) reduces phosphorylated ERK, STAT3, and Akt levels in THP-1, HL-60, and U937 cells. It reduces tumor volume without affecting body weight in a U937 mouse xenograft model when administered at a dose of 55 mg/kg every other day. CP-EPS8-NLS (50 mg/kg every other day), alone or in combination with daunorubicin , decreases tumor volume in a KG-1 acute myeloid leukemia (AML) mouse xenograft model.

产品文档 Product Documents

Purity:>95.00%

化学性质Chemical Properties

同义词
CP-Epidermal Growth Factor Receptor Kinase Substrate 8-NLS
化学名
0
SMILES
FC(F)(F)C(O)=O.NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC(CNC([C@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CC(N)=O)NC([C@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H](CO)NC([C@H](CCC(N)=O)NC([C@@H]1CCCN1C([C@@H]2CCCN2C([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCC(N)=O)NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H](CCCCN)NC([C@H](CCCNC(N)=N)NC(CNC(C)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O
分子式
C135H256N62O30 • XCF3COOH
分子量
3227.87702 g/mol
溶解性
DMSO: Soluble: ≥10 mg/mL; PBS (pH 7.2): Soluble: ≥10 mg/mL
保存条件
-20°C
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至 37°C,然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备 RT,或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol